Jacobson, Terry A <br/><br/>
A new pure ω-3 eicosapentaenoic acid ethyl ester (AMR101) for the management of hypertriglyceridemia: the MARINE trial.  [electronic resource] 

 -  Expert review of cardiovascular therapy  Jun 2012 
 - 687-95 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1744-8344 
<br/><br/><label>Standard No.: </label>10.1586/erc.12.56  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Cholesterol, LDL--blood<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Eicosapentaenoic Acid--administration & dosage<br/>Female<br/>Humans<br/>Hypertriglyceridemia--drug therapy<br/>Male<br/>Middle Aged<br/>Treatment Outcome<br/>Triglycerides--blood